Volkmann MedizinTechnik GmbH Company brings together a team of professionals from different regions and countries.

The Company employs 190 people, including:

More than 70% of the company’s jobs are provided directly by the company’s production facilities.
This structure is streamlined allowing us to make decisions quickly, follow our strategy and provide exceptional client service wherever in the world our clients do business.

The main production sites of the Company are currently located in India, China and Pakistan.
New investment project was recently approved for the construction of a plant in Germany, the main activity of which is planned to manufacture high-tech medical products.
At the same time, it is also planned to maintain and develop the company’s international sites in order to optimize resources in production, provide high quality products and preserve jobs.
The company’s production sites are certified in accordance with international standards of good manufacturing practices. We are constantly improving, creating the best experience for our partners and customers.

Quality products are our number one priority. All our business processes – from the development of medical products to supplies and sales – are concentrated in Germany – in Karlsruhe, Baden-Württemberg. Intensive research and close cooperation with medical practitioners ensure the convenience and safety of using our products.

The Company maintains an excellent value for money of its products, and also provides a high level of customer service: We pride ourselves on the commitment to “No Compromise” quality. For us there cannot be any compromise when it comes to quality.

We are working to prove ourselves in the German and European markets with research, development, production and sales of medical products. Since 2017, we have been working on the globalization of Volkmann MedizinTechnik GmbH products and the development of a network of our dealer centers around the world.

In the near future, several representative offices of the Company are expected to be opened, including in Georgia, Brazil, India, Russia, Kazakhstan, Belarus, and Armenia.